Marc Tessier-lavigne - Net Worth and Insider Trading
Marc Tessier-lavigne Net Worth
The estimated net worth of Marc Tessier-lavigne is at least $51 Million dollars as of 2024-05-28. Marc Tessier-lavigne is the Director of Denali Therapeutics Inc and owns about 2,107,225 shares of Denali Therapeutics Inc (DNLI) stock worth over $40 Million. Marc Tessier-lavigne is the Director of Juno Therapeutics Inc and owns about 75,000 shares of Juno Therapeutics Inc (JUNO) stock worth over $7 Million. Marc Tessier-lavigne is also the Director of Regeneron Pharmaceuticals Inc and owns about 2,269 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $2 Million. Besides these, Marc Tessier-lavigne also holds Agios Pharmaceuticals Inc (AGIO) . Details can be seen in Marc Tessier-lavigne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marc Tessier-lavigne has not made any transactions after 2022-11-23 and currently still holds the listed stock(s).
Transaction Summary of Marc Tessier-lavigne
Marc Tessier-lavigne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc Tessier-lavigne owns 5 companies in total, including Denali Therapeutics Inc (DNLI) , Regeneron Pharmaceuticals Inc (REGN) , and Agios Pharmaceuticals Inc (AGIO) among others .
Click here to see the complete history of Marc Tessier-lavigne’s form 4 insider trades.
Insider Ownership Summary of Marc Tessier-lavigne
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DNLI | Denali Therapeutics Inc | 2022-11-23 | director |
REGN | Regeneron Pharmaceuticals Inc | 2022-10-03 | director |
AGIO | Agios Pharmaceuticals Inc | 2013-07-23 | director |
2016-06-17 | director | ||
2011-12-12 | director |
Marc Tessier-lavigne Latest Holdings Summary
Marc Tessier-lavigne currently owns a total of 4 stocks. Among these stocks, Marc Tessier-lavigne owns 2,107,225 shares of Denali Therapeutics Inc (DNLI) as of November 23, 2022, with a value of $40 Million and a weighting of 79.89%. Marc Tessier-lavigne owns 75,000 shares of Juno Therapeutics Inc (JUNO) as of December 18, 2014, with a value of $7 Million and a weighting of 12.87%. Marc Tessier-lavigne also owns 2,269 shares of Regeneron Pharmaceuticals Inc (REGN) as of October 3, 2022, with a value of $2 Million and a weighting of 4.41%. The other 1 stocks Agios Pharmaceuticals Inc (AGIO) have a combined weighting of 2.83% among all his current holdings.
Latest Holdings of Marc Tessier-lavigne
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc | 2022-11-23 | 2,107,225 | 19.21 | 40,479,792 |
JUNO | Juno Therapeutics Inc | 2014-12-18 | 75,000 | 86.96 | 6,522,000 |
REGN | Regeneron Pharmaceuticals Inc | 2022-10-03 | 2,269 | 985.02 | 2,235,010 |
AGIO | Agios Pharmaceuticals Inc | 2013-07-23 | 45,454 | 31.50 | 1,431,801 |
Holding Weightings of Marc Tessier-lavigne
Marc Tessier-lavigne Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc Tessier-lavigne has made a total of 11 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 20,000 shares on November 23, 2022, which brought Marc Tessier-lavigne around $609,600.
According to the SEC Form 4 filings, Marc Tessier-lavigne has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 0 shares on December 18, 2014, which brought Marc Tessier-lavigne around $0.
According to the SEC Form 4 filings, Marc Tessier-lavigne has made a total of 7 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 10,838 shares on October 3, 2022, which brought Marc Tessier-lavigne around $8 Million.
More details on Marc Tessier-lavigne's insider transactions can be found in the Insider Trading History of Marc Tessier-lavigne table.Insider Trading History of Marc Tessier-lavigne
- 1
Marc Tessier-lavigne Trading Performance
Marc Tessier-lavigne Ownership Network
Ownership Network List of Marc Tessier-lavigne
Ownership Network Relation of Marc Tessier-lavigne
Marc Tessier-lavigne Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Marc Tessier-lavigne is the director of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include CFO and Treasurer Steve E. Krognes , COO and Secretary Alexander O. Schuth , and Chief Medical Officer Carole Ho .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Marc Tessier-lavigne made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 106,621 shares made by Alexander O. Schuth , a net sale of 42,800 shares made by Carole Ho , and a net sale of 186,802 shares made by Ryan J. Watts .
In summary, during the past 3 months, insiders sold 95,832 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 95,832 shares. During the past 18 months, 460,892 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 460,892 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Marc Tessier-lavigne Mailing Address
Above is the net worth, insider trading, and ownership report for Marc Tessier-lavigne. You might contact Marc Tessier-lavigne via mailing address: 1 Dna Way, South San Francisco Ca 94080.